Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QR4M | ISIN: FI4000490875 | Ticker-Symbol: 7XE
Frankfurt
24.01.25
08:07 Uhr
2,970 Euro
+0,240
+8,79 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NIGHTINGALE HEALTH OYJ Chart 1 Jahr
5-Tage-Chart
NIGHTINGALE HEALTH OYJ 5-Tage-Chart
RealtimeGeldBriefZeit
2,8302,99020:56

Aktuelle News zur NIGHTINGALE HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoNightingale Health announces the performance metrics of its latest generation disease risk assessments to be rolled out in Singapore and the United States1
23.12.24Conversion of Nightingale Health Plc's EMP shares to Series B shares1
20.12.24Nightingale Health Plc - Managers' Transactions - Olli Karhi1
18.12.24Nightingale Health Plc appoints Lago Kapital as liquidity provider2
13.12.24Nightingale Health Plc: Subscription of Series B shares with option rights2
04.12.24Study published in Nature Communications: Nightingale Health outperforms genetic testing in chronic disease risk detection and makes the promise of preventative health a reality1
NIGHTINGALE HEALTH Aktie jetzt für 0€ handeln
29.11.24Nightingale Health announces opening of its Singapore laboratory2
27.11.24Inside information: Nightingale Health is investigating the transfer of its B shares to the Main Market of Nasdaq Helsinki and adding the OTCQX market as an additional trading venue in the U.S.1
14.11.24Nightingale Health Asia achieves ISO 13485:2016 certification and completes regulatory readiness to launch its blood testing service in Singapore2
08.11.24Resolutions of the Annual General Meeting and the Board of Directors' organizational meeting of Nightingale Health Plc3
06.11.24Renowned international expert in medicine Dr. Charles Alessi joins Nightingale Health UK as Chief Medical Officer2
30.10.24Nightingale Health and Boston Heart Diagnostics have successfully completed their pilot and move to the production phase expanding the use of Nightingale's Health Check in the US1
10.10.24Notice to the Annual General Meeting of Nightingale Health Plc1
10.10.24Nightingale Health's Annual Report for financial year 2023-2024 has been published1
09.10.24Conversion of Nightingale Health Plc's Series A shares to Series B shares1
20.09.24Nightingale Health's Board of Directors resolved on amendment to CEO's incentive program1
20.09.24Nightingale Health Oyj: Nightingale Health Plc Financial Statements Release 1 July 2023 - 30 June 202495 Nightingale Health Plc Company release 20 September 2024 at 9:00 a.m. (EEST)Nightingale Health Group's Financial Statements Release 1 July 2023 - 30 June 2024 (unaudited) Nightingale's Financial Statements...
► Artikel lesen
19.09.24Nightingale Health receives third regulatory approval for healthcare use from Health Sciences Authority in Singapore1
05.09.24Nightingale Health to publish Financial Statements Release for financial year July 2023 - June 2024 on 20 September 20241
20.08.24Nightingale Health attains UKCA marking for its blood analysis technology to bring its technology to healthcare use in the United Kingdom1
Seite:  Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1